NASAL MUCOSAL HYPERTROPHY

This adverse event was reported 20 times

NASAL MUCOSAL HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACTERIOSTATIC WATER 1 0.0024
1 PINDOLOL 1 0.0012
2 METRELEPTIN 1 0.0008
3 SAW PALMETTO 1 0.0005
4 THIOGUANINE 1 0.0005
5 OXYMETAZOLINE HYDROCHLORIDE 1 0.0002
6 ETODOLAC 1 0.0002
7 PENTOSAN POLYSULFATE SODIUM 1 0.0001
8 FOSAPREPITANT DIMEGLUMINE 1 0.0001
9 CETIRIZINE HYDROCHLORIDE TABLETS 2 0.0001
See all drugs enriched for association with NASAL MUCOSAL HYPERTROPHY

NASAL MUCOSAL HYPERTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Leptin Analog [EPC] 1 0.0008
1 Anti-IgE [EPC] 2 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Alkylating Drug [EPC] 2 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
5 Progestin [EPC] 1 0.0000
6 beta-Adrenergic Blocker [EPC] 1 0.0000
7 Corticosteroid [EPC] 3 0.0000
8 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
9 Platelet Aggregation Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with NASAL MUCOSAL HYPERTROPHY